EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice

Baron J Bechtold iD, Katherine D Lynch, Victoria O Oyanna iD, M Ridge Call, Laura A White, Tyler N Graf, Nicholas H Oberlies, John D Clarke iD

Drug Metabolism and Disposition · 2024

DOI: 10.1124/dmd.123.001607 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Baron J Bechtold und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences (B.J.B., K.D.L., V.O.O., M.R.C., J.D.C.) and Washington Animal Disease Diagnostic Laboratory (L.A.W.), Washingt…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Organic Anion Transporters, Silymarin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseOrganic Anion TransportersSilymarinHumansMaleFemaleMiceAnimalsMice, TransgenicSolute Carrier Organic Anion Transporter Family Member 1B3Liver-Specific Organic Anion Transporter 1LiverMembrane Transport ProteinsDrug Interactions

Substanzen

Solute Carrier Organic Anion Transporter Family Member 1B3Liver-Specific Organic Anion Transporter 1Organic Anion TransportersMembrane Transport ProteinsSilymarinSLCO1B1 protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences (B.J.B., K.D.L., V.O.O., M.R.C., J.D.C.) and Washington Animal Disease Diagnostic Laboratory (L.A.W.), Washington State University, Pullman, Washington; and Department of Chemistry…

ORCID-Profile: Baron J Bechtold, Victoria O Oyanna, John D Clarke

Förderung

  • NCCIH NIH HHS

Zitieren

APA

Bechtold, B. J., Lynch, K. D., Oyanna, V. O., Call, M. R., White, L. A., Graf, T. N., Oberlies, N. H., & Clarke, J. D. (2024). Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001607

Vancouver

Bechtold BJ, Lynch KD, Oyanna VO, Call MR, White LA, Graf TN, et al. Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.123.001607

BibTeX
@article{Bechtold2024,
  author = {Bechtold, Baron J and Lynch, Katherine D and Oyanna, Victoria O and Call, M Ridge and White, Laura A and Graf, Tyler N and Oberlies, Nicholas H and Clarke, John D},
  title = {Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B Mice},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  doi = {10.1124/dmd.123.001607}
}
Kostenlos starten →